Abstract
BackgroundThe CACNA1C gene was defined as a risk gene for schizophrenia in a large genome-wide association study of European ancestry performed by the Psychiatric Genomics Consortium. Previous meta-analyses focused on the association between the CACNA1C gene rs1006737 and schizophrenia. The present study focused on whether there was an ancestral difference in the effect of the CACNA1C gene rs1006737 on schizophrenia. rs2007044 and rs4765905 were analyzed for their effect on the risk of schizophrenia.MethodsPooled, subgroup, sensitivity, and publication bias analysis were conducted.ResultsA total of 18 studies met the inclusion criteria, including fourteen rs1006737 studies (15,213 cases, 19,412 controls), three rs2007044 studies (6007 cases, 6518 controls), and two rs4765905 studies (2435 cases, 2639 controls). An allele model study also related rs2007044 and rs4765905 to schizophrenia. The overall meta-analysis for rs1006737, which included the allele contrast, dominant, recessive, codominance, and complete overdominance models, showed significant differences between rs1006737 and schizophrenia. However, the ancestral-based subgroup analysis for rs1006737 found that the genotypes GG and GG + GA were only protective factors for schizophrenia in Europeans. In contrast, the rs1006737 GA genotype only reduced the risk of schizophrenia in Asians.ConclusionsRs1006737, rs2007044, and rs4765905 of the CACNA1C gene were associated with susceptibility to schizophrenia. However, the influence model for rs1006737 on schizophrenia in Asians and Europeans demonstrated both similarities and differences between the two ancestors.
Highlights
The CACNA1C gene was defined as a risk gene for schizophrenia in a large genome-wide association study of European ancestry performed by the Psychiatric Genomics Consortium
Fatima et al [11] detected a significant difference in the genotype and allele frequencies for the rs4765905 polymorphism between patients and controls, confirming the hypothesis that the CACN A1C gene was associated with schizophrenia in the Pakistani sample
Studies that did not conform to the inclusion criteria were excluded, and 18 studies were available for meta-analysis (Fig.1)
Summary
The CACNA1C gene was defined as a risk gene for schizophrenia in a large genome-wide association study of European ancestry performed by the Psychiatric Genomics Consortium. The present study focused on whether there was an ancestral difference in the effect of the CACNA1C gene rs1006737 on schizophrenia. Liu et al BMC Medical Genetics (2020) 21:159 suggested that the CACNA1C genotype may explain inter-individual differences in the amygdala volume among patients with schizophrenia in the German sample. Fatima et al [11] detected a significant difference in the genotype and allele frequencies for the rs4765905 polymorphism between patients and controls, confirming the hypothesis that the CACN A1C gene was associated with schizophrenia in the Pakistani sample. Previous study [12] have shown that disease-related SNPs in the CACNA1C gene (including rs1006737 and rs4765905) were proven to be expression quantitative trait loci (eQTLs), which are located in a region interacting with the promoter of CACNA1C, and may regulate the expression of CACN A1C in the brain
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
